Bahrain vs Hong Kong: HIV-positive TB patients on ART (antiretroviral therapy)
Bahrain
100.0%
in 2023
Hong Kong
100.0%
in 2024
Bahrain rank
1st
Hong Kong rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bahrain
- Hong Kong
How they compare
Bahrain currently reports 100.0% against 100.0% in Hong Kong, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2008 it was Hong Kong ahead.
Bahrain ranks 1st and Hong Kong ranks 1st of 144 countries.
Across the 3 decades both report, Bahrain averaged higher in 1 and Hong Kong in 2.
Head to head by decade
| Decade | Bahrain | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 29.5% | 16.5% | Hong Kong |
| 2010s | 63.5% | 37.0% | 26.5% | Bahrain |
| 2020s | 57.5% | 90.2% | 32.8% | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bahrain or Hong Kong?
- Bahrain, at 100.0% against 100.0% in Hong Kong as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bahrain and Hong Kong?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Hong Kong?
- 10 years are reported by both, from 2008 to 2023.
- How do Bahrain and Hong Kong rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bahrain ranks 1st and Hong Kong ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.